ADDENDUM ITo Master Agreement • April 20th, 2006 • Warner Chilcott CORP • Pharmaceutical preparations
to MASTER AGREEMENT (the “Master Agreement”) dated 1 April 2003 between GALEN (CHEMICALS) LIMITED, 4 Adelaide Street, Dun Laoghaire, Co. Dublin, Ireland (“GALEN”) and LEO Pharma A/S, Industriparken 55, DK-2750 Ballerup, Denmark (“LEO”) (this “Addendum”).
LICENSE, SUPPLY AND DEVELOPMENT AGREEMENT between WARNER CHILCOTT COMPANY, INC. and LEO Pharma A/SLicense, Supply and Development Agreement • April 20th, 2006 • Warner Chilcott CORP • Pharmaceutical preparations • New York
WHEREAS WCCI and LEO wish to explore certain opportunities in relation to topical treatment and prevention of psoriasis with calcipotriol (calcipotriene) alone or in combination with steroids in the Territory;
FIRST AMENDMENT TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • April 20th, 2006 • Warner Chilcott CORP • Pharmaceutical preparations • New York
THIS AMENDMENT (“Amendment”) is made, effective as of the date signed by the last party to sign below, to the Asset Purchase Agreement (the “Asset Purchase Agreement”) dated September 30, 2005 between Bristol-Myers Squibb Company, a Delaware corporation, headquartered at 345 Park Avenue, New York, New York 10145 (“Seller”), and Warner Chilcott Company, Inc., a Puerto Rican corporation (“Purchaser”).
ContractWarner Chilcott CORP • April 20th, 2006 • Pharmaceutical preparations • New York
AMENDMENT dated as of March 29, 2005 (this “Amendment”), to the Credit Agreement dated as of January 18, 2005 (the “Credit Agreement”), among WARNER CHILCOTT HOLDINGS COMPANY III, LIMITED, a company organized under the laws of Bermuda (the “BR Borrower”), WARNER CHILCOTT CORPORATION, a Delaware corporation (the “US Borrower”), WARNER CHILCOTT COMPANY, INC., a corporation organized under the laws of Puerto Rico (the “PR Borrower”, and together with the BR Borrower and the US Borrower, the “Borrowers”), the Lenders (as defined in the introductory paragraph to the Credit Agreement), and CREDIT SUISSE FIRST BOSTON, as administrative agent (in such capacity, the “Administrative Agent”).
Right of First Refusal Agreement betweenAgreement • April 20th, 2006 • Warner Chilcott CORP • Pharmaceutical preparations • New York
Capitalized terms not otherwise defined herein shall have the meanings set forth in Article 1 of this Right of First Refusal Agreement (this “Agreement”).
TRADEMARK ASSIGNMENTTrademark Assignment • April 20th, 2006 • Warner Chilcott CORP • Pharmaceutical preparations
THIS ASSIGNMENT OF TRADEMARKS (this “Assignment”) is made as of the 1st day of January, 2006, by and among Westwood-Squibb Pharmaceuticals, Inc. (“Assignor”), a subsidiary of Bristol-Myers Squibb Company, a Delaware corporation (“Seller”), Warner Chilcott Company, Inc., a Puerto Rican corporation (“WCCI”) and LEO Pharma A/S, a Danish entity (“Assignee”).
AMENDED AND RESTATED LICENSE AND SUPPLY AGREEMENT between WARNER CHILCOTT COMPANY, INC. and LEO Pharma A/SLicense and Supply Agreement • April 20th, 2006 • Warner Chilcott CORP • Pharmaceutical preparations • New York
WHEREAS, LEO has discovered and developed the Compound and Manufactures pharmaceutical products containing the Compound for human therapeutic use;
